Call Invite Today @ 1230PM ET | Dr. Aditi Bhargava, Professor, Director of Laboratory Research UCSF

09/07/22 10:31AM EDT

The bull thesis for MRNA and and PFE beyond the Public Health Emergency has consisted, in part, of wringing a higher price out of commercial insurers - something former White House Advisor, Andy Slavitt, has thrown cold water on - and applying the mRNA technology to other vaccines and uses beyond SARS-CoV-2. Dr. Bhargava has done extensive research in this area and offers a salient and objective view of the current state of the research. 

Connection Details:

Today, 12:30 PM ET (Add to Outlook)

Live Video Only. Link here: https://app.hedgeye.com/feed_items/121756?with_category=48-health-policy

(Last minute, I know. So look for replay link later today!)

Emily Evans
Managing Director – Health Policy


Twitter
LinkedIn

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.